China Resources Pharmaceutical Group
3320.HK
#2974
Rank
โ‚น374.30 B
Marketcap
โ‚น59.58
Share price
0.38%
Change (1 day)
10.34%
Change (1 year)

Revenue for China Resources Pharmaceutical Group (3320.HK)

Revenue in 2022: โ‚น2.846 Trillion

According to China Resources Pharmaceutical Group's latest financial reports the company's current revenue (TTM ) is โ‚น2.846 Trillion. In 2022 the company made a revenue of โ‚น2.846 Trillion an increase over the revenue in the year 2021 that were of โ‚น2.658 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for China Resources Pharmaceutical Group from 2013 to 2022

Annual revenue

Year Revenue Change
2022โ‚น2.846 T7.09%
2021โ‚น2.658 T17.47%
2020โ‚น2.262 T-1.52%
2019โ‚น2.297 T8.38%
2018โ‚น2.120 T9.69%
2017โ‚น1.932 T9.28%
2016โ‚น1.768 T6.86%
2015โ‚น1.655 T8.05%
2014โ‚น1.531 T16.04%
2013โ‚น1.320 T